Next Issue

March 2025

Don’t miss out – sign up to our free industry-leading magazine and newsletters

In the next issue, we continue to cover the latest in radiopharmaceuticals, with a focus on major deals in this arena. Additional stories will explore the development of treatments for alcohol use disorder, the growing use of artificial intelligence (AI) in drug discovery, and more.

EDITORIAL

Editor |Manasi Vaidya

Deputy Editor | Ross Law

Writers | Robert Barrie, Abigail Beaney, Natasha Spencer-Jolliffe

Graphic Designers | Anett Arc, Noemi Balint, Will Ingham, Miriam Garofalo

ADVERTISING

Sales Manager | Tom McCormick
+44 207 8669440

Pharma Technology Focus is powered by H5mag
Read past issues of Pharma Technology Focushere

Go to article: Home | The biggest challenges clinical trials will face in 2025Go to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: In DepthGo to article: The biggest challenges clinical trials will face in 2025Go to article: Investors optimistic about continued biotech and medtech IPO resurgence in 2025Go to article: ADCs breach barriers to become mainstream cancer treatmentGo to article: WHO trial guidance goes beyond race and gender when tackling diversityGo to article: Mega M&A at JP Morgan Conference 2025 — is biopharma M&A poised for a rebound?Go to article: From Davids to Goliaths: the GLP-1RA gold rushGo to article: Radiopharmaceutical trials face extra complexities due to nuclear red tapeGo to article: PCI Pharma ServicesGo to article: Endress+HauserGo to article: ListingsGo to article: EventsGo to article: Event: Digital Health Festival 2025Go to article: Pharmaceutical Technology Excellence Awards 2024 winnersGo to article: Buyer's GuidesGo to article: Next issue